Send feedback

DYSF p.Ser1726Pro

c.5176T>C · rs1573060017 · VCV665724

Likely pathogenic Expert panel
Classification
Likely pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.9219 · ACMG-weighted
gnomAD v4.1
Absent
absent from gnomAD v4.1
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
autosomal recessive limb-girdle muscular dystrophy

ClinGen expert panel — Limb Girdle Muscular Dystrophy VCEP

Likely Pathogenic for autosomal recessive limb-girdle muscular dystrophy. Applied ACMG criteria (verbatim):

PM2_Supporting PP4_Strong PP3 PM3

Curation rationale (ClinGen, verbatim)

The NM_003494.4: c.5059T>C variant in DYSF, which is also known as NM_001130987.2: c.5176T>C p.(Ser1726Pro), is a missense variant predicted to cause substitution of serine by proline at amino acid 1687, p.(Ser1687Pro). This variant has been identified in one individual with a diagnosis of LGMD, where it it was confirmed in trans with a variant classified as pathogenic by the LGMD VCEP (c.2643+1G>A, 1.0 pt, PMID: 36983702) (PM3). This patient displayed progressive limb girdle muscle weakness and significantly reduced or absent dysferlin protein expression in skeletal muscle and blood monocytes, which is highly specific for DYSF-related LGMD (PMID: 36983702; PP4_Strong). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). The computational predictor REVEL gives a score of 0.8, which exceeds the threshold of ≥0.70, evidence that correlates with impact to DYSF function (PP3). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/28/2025): PM3, PP4_Strong, PM2_Supporting, PP3.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.9219likely pathogenic ✓ concordant with ClinVar
REVEL0.795moderately pathogenic-leaning
SaProtLLR -12.18damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 6.2GERP 2, phastCons 1
Regional constrainto/e 0.97unconstrained · MANE · 117 kb · p 0.28 · regional, not allelic
Overall
CADD25.2PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM S1687P vs ClinVar S1726P) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene
DYSF
Protein
p.Ser1726Pro
Coding
c.5176T>C
MANE Select
NM_001130987
dbSNP
rs1573060017
Type
single nucleotide variant
Location
chr2:71665163 (GRCh38)
Gene constraint
LOEUF 0.836 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 79.25 · 11 PDB
Residue 1726
a β-strand
Full DYSF gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dysf-p-ser1726pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown